Participation of D1–4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe6 angiotensin IV

2010 ◽  
Vol 34 (3) ◽  
pp. 343-350 ◽  
Author(s):  
Jan J. Braszko
Keyword(s):  
Dopamine Receptors ◽  
Cognitive Effects ◽  
Angiotensin Iv

Effect of D3 dopamine receptors blockade on the cognitive effects of angiotensin IV in rats

Neuropeptides ◽  
2008 ◽  
Vol 42 (3) ◽  
pp. 301-309 ◽  
Author(s):  
Jan J. Braszko ◽  
Przemysław Wielgat ◽  
Anna Walesiuk
Keyword(s):  
Dopamine Receptors ◽  
Cognitive Effects ◽  
Angiotensin Iv

Blockade of pro-cognitive effects of angiotensin IV and physostigmine in mice by oxytocin antagonism

2012 ◽  
Vol 683 (1-3) ◽  
pp. 155-160 ◽  
Author(s):  
Paul R. Gard ◽  
Cathy Naylor ◽  
Sofiya Ali ◽  
Clare Partington
Keyword(s):  
Cognitive Effects ◽  
Angiotensin Iv

scholarly journals Low-dose chronic prenatal alcohol exposure abolishes the pro-cognitive effects of angiotensin IV

2017 ◽  
Vol 329 ◽  
pp. 140-147 ◽  
Author(s):  
Sara Fidalgo ◽  
Charlotte Skipper ◽  
Abigail Takyi ◽  
Aisling McIver ◽  
Theodoros Tsiligkaridis ◽  
...  
Keyword(s):  
Low Dose ◽  
Prenatal Alcohol Exposure ◽  
Alcohol Exposure ◽  
Cognitive Effects ◽  
Angiotensin Iv ◽  
Prenatal Alcohol

Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma

2019 ◽  
Vol 28 (3) ◽  
pp. 548-552
Author(s):  
Andro Košec ◽  
Ivan Kruljac ◽  
Jakov Ajduk
Keyword(s):  
Dopamine Receptors ◽  
Male Patient ◽  
Endolymphatic Hydrops ◽  
Young Male ◽  
Oral Steroid ◽  
Case Description ◽  
Diuretic Treatment ◽  
Potential Therapeutic Role ◽  
Transient Improvement ◽  
Systemic Glucocorticoids

Objective Current recommendations for cochlear hydrops treatment include systemic glucocorticoids and diuretics. Cochlear cells express dopamine receptors, although their role is unknown in the pathophysiology of cochlear hydrops. Case Description We report the case of remission of recurrent right-sided cochlear hydrops in a young male patient treated with bromocriptine due to pituitary macroprolactinoma. Transient improvement was observed after oral steroid and diuretic treatment, but cochlear hydrops recurred until the dose of bromocriptine was increased to 10 mg daily. Conclusion Bromocriptine may stimulate dopamine receptors in cochlear cells with potential therapeutic role in patients with cochlear hydrops. There are no widely accepted and effective treatments for endolymphatic hydrops, and identifying potential new and efficacious therapeutics is of high relevance.

Sign in / Sign up

Export Citation Format

Share Document